{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:50:56Z","timestamp":1768035056764,"version":"3.49.0"},"reference-count":34,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00514","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T03:49:26Z","timestamp":1503287366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Yishu","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changge","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Hui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat.","volume":"51","author":"Abdel-Salam","year":"2005","journal-title":"Pharmacol. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.","volume":"46","author":"Abe","year":"2007","journal-title":"J. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/gut.2008.150748","article-title":"Coagulation and fibrosis in chronic liver disease.","volume":"57","author":"Calvaruso","year":"2008","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats.","volume":"64","author":"Cerini","year":"2016","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.154","article-title":"Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.drudis.2015.10.015","article-title":"Emerging therapeutic targets for the treatment of hepatic fibrosis.","volume":"21","author":"Fagone","year":"2016","journal-title":"Drug Discov. Today"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4986","article-title":"Hematoxylin and eosin staining of tissue and cell sections.","volume":"5","author":"Fischer","year":"2008","journal-title":"CSH Protoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1164\/rccm.2201082","article-title":"Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.","volume":"168","author":"Gunther","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis.","volume":"66","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-anchem-061010-113911","article-title":"Heparin characterization: challenges and solutions.","volume":"44","author":"Jones","year":"2011","journal-title":"Annu. Rev. Anal. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.biomaterials.2010.10.023","article-title":"The use of low molecular weight heparin\u2013pluronic nanogels to impede liver fibrosis by inhibition the TGF-\u03b2\/Smad signaling pathway.","volume":"32","author":"Lee","year":"2011","journal-title":"Biomaterials"},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd724","article-title":"Novel drug development opportunities for heparin.","volume":"1","author":"Lever","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118481","article-title":"Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1alpha, VEGF and TGF-beta1.","volume":"10","author":"Li","year":"2015","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.hepres.2006.07.004","article-title":"Long-term administering low anticoagulant activity heparin can lessen rat hepatic fibrosis induced by either CCl4 or porcine serum injection.","volume":"36","author":"Li","year":"2006","journal-title":"Hepatol. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11010-009-0060-2","article-title":"The preventive effects of heparin-superoxide dismutase on carbon tetrachloride-induced acute liver failure and hepatic fibrosis in mice.","volume":"327","author":"Liu","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review.","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv. Pharmacol. Sci."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/910743","article-title":"Heparin and related drugs: beyond anticoagulant activity.","volume":"2013","author":"Page","year":"2013","journal-title":"ISRN Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ.","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrgastro.2015.224","article-title":"Liver fibrosis in 2015: crucial steps towards an effective treatment.","volume":"13","author":"Poelstra","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice.","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrgastro.2014.36","article-title":"Management of portal vein thrombosis in liver cirrhosis.","volume":"11","author":"Qi","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: structure and function.","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Nat. Prod. Rep."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153118","article-title":"Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1 beta or TNF-alpha release from human hepatic stellate cells.","volume":"11","author":"Robert","year":"2016","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis - a common pathway to organ injury and failure reply.","volume":"373","author":"Rockey","year":"2015","journal-title":"New Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.actbio.2011.10.025","article-title":"Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.","volume":"8","author":"Saito","year":"2012","journal-title":"Acta Biomater."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.","volume":"40","author":"Sakaida","year":"2004","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature20611","article-title":"Identification of an atypical monocyte and committed progenitor involved in fibrosis.","volume":"541","author":"Satoh","year":"2017","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways.","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1183\/09031936.06.00069005","article-title":"Inhaled heparin in cystic fibrosis.","volume":"27","author":"Serisier","year":"2006","journal-title":"Eur. Respir. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.carbpol.2013.09.052","article-title":"Controllable production of low molecular weight heparins by combinations of heparinase I\/II\/III.","volume":"101","author":"Wu","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease.","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.carbpol.2017.05.102","article-title":"Discovery of enzymatically depolymerized heparins capable of treating Bleomycin-induced pulmonary injury and fibrosis in mice.","volume":"174","author":"Yan","year":"","journal-title":"Carbohydr. Polym."},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.carbpol.2016.12.037","article-title":"Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: a review.","volume":"160","author":"Yan","year":"","journal-title":"Carbohydr. Polym."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00514\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T03:49:26Z","timestamp":1503287366000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00514\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":34,"alternative-id":["10.3389\/fphar.2017.00514"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00514","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"article-number":"514"}}